Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myeloid

Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.

3,108 public trials 620 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myeloid trial results

Completed

Italian Registry on the Prevalence of IDH1/IDH2 Mutations in Patients With Acute Myeloid Leukemia

NCT02986620

Conditions
AML, Adult, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Aon Ss. Antonio E Biagio E C. Arrigo - Alessandria - Soc Ematologia Alessandria, Italy
  • Aou Consorziale Policlinico - Bari - Uo Ematologia Con Trapianto Bari, Italy
  • Aou Di Bologna - Policlinico S. Orsola-Malpighi - Uoc Ematologia Bologna, Italy
  • Istituto di Ematologia "Lorenzo e A. Seragnoli" - Università degli Studi di Bologna - Policlinico S. Orsola - Malpighi Bologna, Italy
View all 24 locations
View Trial Details
Completed

Nilotinib and Imatinib Mesylate in Treating Patients With Early Chronic Phase Chronic Myelogenous Leukemia

NCT00769327

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
Locations
  • Centro Oncologico Basilicata Rionero in Vulture, Potenza, Italy
  • Ospedale Civile Alessandria Alessandria, Italy
  • Dipartimento Area Medica P.O. Ascoli Piceno, Italy
  • S.G. Moscati Hospital Avellino, Italy
View all 37 locations
View Trial Details
Completed

A Study of Venetoclax in Combination With Cobimetinib and Venetoclax in Combination With Idasanutlin in Patients With Relapsed or Refractory Acute Myeloid Leukemia Who Are Not Eligible for Cytotoxic Therapy

NCT02670044

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +4 more
Locations
  • USC Norris Cancer Center Los Angeles, California, United States
  • UC Davis; Comprehensive Cancer Center Sacramento, California, United States
  • Univ of Calif, San Francisco San Francisco, California, United States
  • University of Colorado Aurora, Colorado, United States
View all 17 locations
View Trial Details
Completed

Open Label Study of Subcutaneous Homoharringtonine (Omacetaxine Mepesuccinate) in Patients With Advanced CML

NCT00462943

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations
  • Teva Investigational Site 303 Los Angeles, California, United States
  • Teva Investigational Site 308 Beech Grove, Indiana, United States
  • Teva Investigational Site 311 Baltimore, Maryland, United States
  • Teva Investigational Site 305 Buffalo, New York, United States
View all 29 locations
View Trial Details
Completed

Evaluating the Efficacy and Safety of Bemcentinib in Patients With Myelodysplastic Syndromes

NCT03824080

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
Locations
  • CHU Hôtel Dieu Service d'Hématologie Clinique Nantes, Nantes Cedex 1, France
  • Service d'Hématologie Séniors Paris, Paris 7, France
  • Hôpital Archet 1 Service d'Hématologie Clinique Nice, France
  • Universitätsklinikum Dresden Dresden, Germany
View Trial Details
Completed

Double Cord Versus Haploidentical (BMT CTN 1101)

NCT01597778

Conditions
Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt Lymphoma, +30 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Arizona Cancer Center Phoenix, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • University of California at Los Angeles Los Angeles, California, United States
View all 39 locations
View Trial Details
Completed

Combined Tretinoin and Arsenic Trioxide for Patients With Newly Diagnosed Acute Promyelocytic Leukemia Followed by Risk-Adapted Postremission Therapy

NCT01404949

Conditions
Acute Promyelocytic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations
  • University of Southern California Los Angeles, California, United States
  • Northwestern University Evanston, Illinois, United States
  • National Heart, Lung, and Blood Institute (NIH) Bethesda, Maryland, United States
  • Memorial Sloan Kettering at Basking Ridge Basking Ridge, New Jersey, United States
View Trial Details

Related conditions